Aerovate Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Aerovate Therapeutics had annual revenue of 0.00 with ― growth.